speb/financial-data huggingface dataset:
HIVE.V balance_sheet (quarterly, 2024-12-31) — Inventory: 260806000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 453030000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -53364000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 85098000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 981000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 3950000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 3836000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 8999000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 12835000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -605000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 85098000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Net Debt: 8825000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 4481000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Net Income: 68160000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 68160000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 68160000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 68160000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 68160000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 68160000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 68160000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -419000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 1786000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -605000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -605000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -419000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 150000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 115690000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -55300000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 434360000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Non Current Accounts Receivable: 2770000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 1586000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1586000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 49866000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -2691000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Normalized Income: -21121883.92
HIVE.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -28464000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 8709000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Operating Income: -20863000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 29229000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 140200735.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 5721000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 164469000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Other Gand A: 3278000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Other Income Expense: 89565000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -106679000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 122000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Other Payable: 1281000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Other Properties: 315950000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 30700000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Payables: 14832000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 17434000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Pretax Income: 68283000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 101000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
HIVE.V income_statement (quarterly, 2024-12-31) — Provision For Doubtful Accounts: 0.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 1128000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -62224000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Receivables: 8910000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 42002000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 18050000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -605000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -351009000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Salaries And Wages: 4293000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 6924000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 519000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 8090000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 140200735.00
HIVE.V income_statement (quarterly, 2024-12-31) — Special Income Charges: 6924000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 3526000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 434360000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 434360000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 161116.08
HIVE.V income_statement (quarterly, 2024-12-31) — Tax Provision: 123000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 478587000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 443359000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 25207000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 434360000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Total Expenses: 50092000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 44227000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 168326000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 14421000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 5568000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Total Unusual Items: 89443000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 89443000.00
HIVE.V cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -9651000.00
HIVE.V balance_sheet (quarterly, 2024-12-31) — Working Capital: 280455000.00
HIVE.V income_statement (quarterly, 2024-12-31) — Write Off: 0.00
HIVE.V income_statement (annual, 2025-03-31) — +Operating Expense: 26570000.00
HIVE.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 9899000.00
HIVE.V income_statement (annual, 2025-03-31) — +Total Revenue: 115279000.00
HIVE.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 31161000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Accounts Payable: 11650000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 11650000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Accounts Receivable: 11758000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 11758000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -221817000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -221817000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 716708000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 716708000.00
HIVE.V cash_flow (annual, 2025-03-31) — Asset Impairment Charge: 0.00
HIVE.V income_statement (annual, 2025-03-31) — Basic Average Shares: 127942571.00
HIVE.V income_statement (annual, 2025-03-31) — Basic EPS: -0.02
HIVE.V cash_flow (annual, 2025-03-31) — Beginning Cash Position: 9678000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 9845000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 103032000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 103032000.00
HIVE.V cash_flow (annual, 2025-03-31) — Capital Expenditure: -174305000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -69751000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 5740000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 5740000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Capital Stock: 0.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
HIVE.V balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 23375000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 23375000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 47511000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 47511000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Cash Financial: 23375000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 23375000.00
HIVE.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 180734000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 66408000.00
HIVE.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -183773000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -93314000.00
HIVE.V cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: 16634000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 40230000.00
HIVE.V cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 4365000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 3962000.00
HIVE.V cash_flow (annual, 2025-03-31) — Change In Receivables: -4743000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: -3553000.00
HIVE.V cash_flow (annual, 2025-03-31) — Change In Working Capital: -378000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -38372000.00
HIVE.V cash_flow (annual, 2025-03-31) — Changes In Cash: 13595000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: 13324000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Common Stock: 0.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
HIVE.V balance_sheet (annual, 2025-03-31) — Common Stock Equity: 449137000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 449137000.00
HIVE.V cash_flow (annual, 2025-03-31) — Common Stock Issuance: 186762000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 65740000.00
HIVE.V income_statement (annual, 2025-03-31) — Cost Of Revenue: 154621000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 40412000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 2254000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2254000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Current Assets: 241715000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 241715000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 2645000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2645000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Current Debt: 39221000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Current Debt: 39221000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 41866000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 41866000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Current Liabilities: 65957000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 65957000.00
HIVE.V cash_flow (annual, 2025-03-31) — Deferred Income Tax: 3642000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 3159000.00
HIVE.V cash_flow (annual, 2025-03-31) — Deferred Tax: 3642000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Deferred Tax: 3159000.00
HIVE.V cash_flow (annual, 2025-03-31) — Depreciation: 64490000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Depreciation: 15743000.00
HIVE.V cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 64490000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 15743000.00
HIVE.V cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 64490000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 15743000.00
HIVE.V income_statement (annual, 2025-03-31) — Diluted Average Shares: 127942571.00
HIVE.V income_statement (annual, 2025-03-31) — Diluted EPS: -0.02
HIVE.V income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: -2996000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 142000.00
HIVE.V income_statement (annual, 2025-03-31) — EBIT: 3902000.00
HIVE.V income_statement (quarterly, 2025-03-31) — EBIT: 3566000.00
HIVE.V income_statement (annual, 2025-03-31) — EBITDA: 68392000.00
HIVE.V income_statement (quarterly, 2025-03-31) — EBITDA: 19309000.00
HIVE.V cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 102000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 206000.00
HIVE.V cash_flow (annual, 2025-03-31) — End Cash Position: 23375000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 23375000.00
HIVE.V cash_flow (annual, 2025-03-31) — Financing Cash Flow: 180734000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 66408000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Finished Goods: 181146000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Finished Goods: 181146000.00
HIVE.V cash_flow (annual, 2025-03-31) — Free Cash Flow: -157671000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -29521000.00
HIVE.V cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -127644000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -50760000.00
HIVE.V cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -18493000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -2060000.00
HIVE.V income_statement (annual, 2025-03-31) — Gain On Sale Of Ppe: 52167000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 35734000.00
HIVE.V income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 17301000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -12985000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 6291000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 6291000.00
HIVE.V income_statement (annual, 2025-03-31) — General And Administrative Expense: 25379000.00
HIVE.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 9207000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Gross PPE: 430211000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 430211000.00
HIVE.V income_statement (annual, 2025-03-31) — Gross Profit: -39342000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Gross Profit: -9251000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 1300000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 1300000.00
HIVE.V cash_flow (annual, 2025-03-31) — Income Tax Paid Supplemental Data: 1387000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 490000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Income Tax Payable: 7954000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 7954000.00
HIVE.V income_statement (annual, 2025-03-31) — Interest Expense: 2290000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Interest Expense: 265000.00
HIVE.V income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 2290000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 265000.00
HIVE.V cash_flow (annual, 2025-03-31) — Interest Paid Supplemental Data: 1358000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 244000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Inventory: 181146000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Inventory: 181146000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Invested Capital: 498558000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 498558000.00
HIVE.V cash_flow (annual, 2025-03-31) — Investing Cash Flow: -183773000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -93314000.00
HIVE.V cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 186762000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 65740000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Land And Improvements: 2244000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 2244000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Line Of Credit: 0.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 0.00
HIVE.V balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 3095000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 3095000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Long Term Debt: 10200000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 10200000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13295000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 13295000.00
HIVE.V cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -6129000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 668000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -25692000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -25692000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 186762000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 65740000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Net Debt: 26046000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Net Debt: 26046000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 14549000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 10998000.00
HIVE.V income_statement (annual, 2025-03-31) — Net Income: -2996000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Net Income: 142000.00
HIVE.V income_statement (annual, 2025-03-31) — Net Income Common Stockholders: -2996000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 142000.00
HIVE.V income_statement (annual, 2025-03-31) — Net Income Continuous Operations: -2996000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 142000.00
HIVE.V income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2996000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 142000.00
HIVE.V income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -2996000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 142000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: -2996000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 142000.00
HIVE.V income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: -2996000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 142000.00
HIVE.V income_statement (annual, 2025-03-31) — Net Interest Income: -2290000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -265000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 247000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -411000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -6129000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 668000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -6129000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 668000.00
HIVE.V income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -2290000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -265000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -3210000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 0.00
HIVE.V balance_sheet (annual, 2025-03-31) — Net PPE: 208394000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 208394000.00
HIVE.V cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -155118000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -67211000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 449137000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 449137000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Non Current Accounts Receivable: 6602000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 6602000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 3209000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 3209000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 3209000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 3209000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 74887000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 74887000.00
HIVE.V income_statement (annual, 2025-03-31) — Normalized EBITDA: -1076000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -3440000.00
HIVE.V income_statement (annual, 2025-03-31) — Normalized Income: -57875720.00
HIVE.V income_statement (quarterly, 2025-03-31) — Normalized Income: -17829710.00
HIVE.V cash_flow (annual, 2025-03-31) — Operating Cash Flow: 16634000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 40230000.00
HIVE.V cash_flow (annual, 2025-03-31) — Operating Gains Losses: -27069000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 62697000.00
HIVE.V income_statement (annual, 2025-03-31) — Operating Income: -65912000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Operating Income: -19150000.00
HIVE.V income_statement (annual, 2025-03-31) — Operating Revenue: 115279000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 31161000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 165615186.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 165615186.00
HIVE.V balance_sheet (annual, 2025-03-31) — Other Current Borrowings: 39221000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 39221000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 760000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 760000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Other Equity Adjustments: 6291000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 6291000.00
HIVE.V income_statement (annual, 2025-03-31) — Other Gand A: 10949000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Other Gand A: 3526000.00
HIVE.V income_statement (annual, 2025-03-31) — Other Income Expense: 69814000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Other Income Expense: 22716000.00
HIVE.V cash_flow (annual, 2025-03-31) — Other Non Cash Items: -31943000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -33544000.00
HIVE.V income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 346000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -33000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Other Payable: 1473000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Other Payable: 1473000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Other Properties: 324935000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 324935000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 24136000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 24136000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Payables: 21077000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Payables: 21077000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 23331000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 23331000.00
HIVE.V income_statement (annual, 2025-03-31) — Pretax Income: 1612000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Pretax Income: 3301000.00
HIVE.V cash_flow (annual, 2025-03-31) — Proceeds From Stock Option Exercised: 101000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
HIVE.V balance_sheet (annual, 2025-03-31) — Properties: 0.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
HIVE.V income_statement (annual, 2025-03-31) — Provision For Doubtful Accounts: -966000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Provision For Doubtful Accounts: 0.00
HIVE.V cash_flow (annual, 2025-03-31) — Purchase Of Business: -25692000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -25692000.00
HIVE.V cash_flow (annual, 2025-03-31) — Purchase Of Investment: -1529000.00
HIVE.V cash_flow (annual, 2025-03-31) — Purchase Of PPE: -174305000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -69751000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Receivables: 11758000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Receivables: 11758000.00
HIVE.V income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 154621000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 40412000.00
HIVE.V income_statement (annual, 2025-03-31) — Reconciled Depreciation: 64490000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 15743000.00
HIVE.V cash_flow (annual, 2025-03-31) — Repayment Of Debt: -6129000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 668000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Retained Earnings: -273862000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -273862000.00
HIVE.V income_statement (annual, 2025-03-31) — Salaries And Wages: 14430000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 5681000.00
HIVE.V cash_flow (annual, 2025-03-31) — Sale Of Investment: 1776000.00
HIVE.V cash_flow (annual, 2025-03-31) — Sale Of PPE: 19187000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 2540000.00
HIVE.V income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 2157000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 692000.00
HIVE.V income_statement (annual, 2025-03-31) — Selling General And Administration: 27536000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 9899000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Share Issued: 165615186.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 165615186.00
HIVE.V income_statement (annual, 2025-03-31) — Special Income Charges: 52167000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Special Income Charges: 35734000.00
HIVE.V cash_flow (annual, 2025-03-31) — Stock Based Compensation: 10888000.00
HIVE.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 4639000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Stockholders Equity: 449137000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 449137000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Tangible Book Value: 449137000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 449137000.00
HIVE.V income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 14588280.00
HIVE.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 4777290.00
HIVE.V income_statement (annual, 2025-03-31) — Tax Provision: 4608000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Tax Provision: 3159000.00
HIVE.V income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.21
HIVE.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
HIVE.V balance_sheet (annual, 2025-03-31) — Total Assets: 531598000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 531598000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Total Capitalization: 459337000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 459337000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Total Debt: 55161000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 55161000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 449137000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 449137000.00
HIVE.V income_statement (annual, 2025-03-31) — Total Expenses: 181191000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Total Expenses: 50311000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 82461000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 82461000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 289883000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 289883000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 16504000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 16504000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Total Tax Payable: 7954000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 7954000.00
HIVE.V income_statement (annual, 2025-03-31) — Total Unusual Items: 69468000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: 22749000.00
HIVE.V income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 69468000.00
HIVE.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 22749000.00
HIVE.V balance_sheet (annual, 2025-03-31) — Working Capital: 175758000.00
HIVE.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 175758000.00
HIVE.V income_statement (annual, 2025-03-31) — Write Off: 0.00
HIVE.V income_statement (quarterly, 2025-06-30) — +Operating Expense: -13028000.00
HIVE.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 45611000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10168000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 34520000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -247198000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 791220000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 182007767.00
HIVE.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.19
HIVE.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 23375000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 122751000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -47357000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 5547000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 24601000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 58295000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 24601000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 52852000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -61956000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 10228000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -9454000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: -17941000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -27395000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1124000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 560521000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 68024000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 51803000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 5148000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 180648000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 2863000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Current Debt: 23919000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 26782000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 52813000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -718000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Deferred Tax: -718000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Depreciation: 22011000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 22011000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 22011000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 192827179.00
HIVE.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.18
HIVE.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 35016000.00
HIVE.V income_statement (quarterly, 2025-06-30) — EBIT: 35953000.00
HIVE.V income_statement (quarterly, 2025-06-30) — EBITDA: 57964000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 102000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 24601000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 52852000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Finished Goods: 47326000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -37129000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -57233000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -1312000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 1312000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 27480000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 8147000.00
HIVE.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 10986000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 572938000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Gross Profit: -6192000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 40507000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 187000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 8091000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Interest Expense: 288000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 288000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 232000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Inventory: 47326000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 595199000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -61956000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 68024000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 2592000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2684000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 10759000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 13443000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 68024000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Net Debt: 10077000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -2832000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Net Income: 35016000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 35016000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 35016000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 35016000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 35016000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 35016000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 35016000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -288000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -126000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -15910000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
HIVE.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -288000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -15948000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 325740000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -45882000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -15910000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 560521000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 3148000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1957000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 1957000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 119198000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 29172000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Normalized Income: 6747931.25
HIVE.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 10228000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 5070000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Operating Income: 6836000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 45611000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 204325008.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 23919000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 883000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 8147000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Other Gand A: 3721000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Other Income Expense: 29117000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -21334000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 325000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -23161000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Other Payable: 1741000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 447595000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 33694000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Payables: 20000000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 25148000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Pretax Income: 35665000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 738000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
HIVE.V income_statement (quarterly, 2025-06-30) — Provision For Doubtful Accounts: -1367000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -126000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -47357000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Receivables: 34520000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 51803000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 22011000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -15910000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -238846000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 7265000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 1475000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 514000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 11500000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 204325008.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -15910000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Special Income Charges: 1312000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 5750000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 560521000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 560521000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 523931.25
HIVE.V income_statement (quarterly, 2025-06-30) — Tax Provision: 649000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.02
HIVE.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 628734000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 571280000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 40225000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 560521000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Total Expenses: 38775000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 68213000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 448086000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 15400000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 8091000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: 28792000.00
HIVE.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 28792000.00
HIVE.V cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -8172000.00
HIVE.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 127835000.00
HIVE.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 13272000.00
HIVE.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 87253000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 20600000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 16994000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -279378000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 871751000.00
HIVE.V income_statement (quarterly, 2025-09-30) — Basic Average Shares: 228137757.00
HIVE.V income_statement (quarterly, 2025-09-30) — Basic EPS: -0.07
HIVE.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 24601000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 146716000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -37582000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 4804000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 22643000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 48301000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Cash Financial: 22643000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 54476000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -46145000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -10612000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 22288000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -23798000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1510000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2281000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 624599000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 71139000.00
HIVE.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 83141000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 9714000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 136674000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2841000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Current Debt: 7400000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 10241000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 53614000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 1019000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Deferred Tax: 1019000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Depreciation: 38292000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 38292000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 38292000.00
HIVE.V income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 228137757.00
HIVE.V income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.07
HIVE.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -15797000.00
HIVE.V income_statement (quarterly, 2025-09-30) — EBIT: -14450000.00
HIVE.V income_statement (quarterly, 2025-09-30) — EBITDA: 23842000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 323000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 22643000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 54476000.00
HIVE.V balance_sheet (quarterly, 2025-09-30) — Finished Goods: 24364000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -48194000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -79810000.00
HIVE.V cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -48000.00
HIVE.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 48000.00
HIVE.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -5392000.00